Sort
141,003 grants matching “cytokine”
Vaccine Production Core
$1,214,090Norman L Letvin · Duke University · U19 · FY2006 · AI
Vaccine Production Core
$1,214,090Duke University · U01 · FY2005 · AI
Studies of the Function of Naturally Occurring and Adaptive T Regulatory Cells
$1,213,990Ethan Shevach · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI
Herpesviruses as Vaccine Vectors for AIDS
$1,213,954David M Knipe · Harvard Medical School · P01 · FY2007 · AI
India International Center for Excellence in Research
$1,213,940Thomas Nutman · National Institute Of Allergy And Infectious Diseases · ZIA · FY2009 · AI
SCOR IN ACUTE LUNG INJURY
$1,213,901University Of Iowa · P50 · FY2001 · HL
Immune Reconstitution
$1,213,839Richard A Koup · Niaid Extramural Activities · Z01 · FY2007 · AI
Effects of HIV SIV on unconventional T cells in immunity to M. tuberculosis in pre adolescents
$1,213,831Charles A. Scanga · University Of Pittsburgh At Pittsburgh · R01 · FY2021 · AI
PACT
$1,213,809John Keach · University Of Wisconsin-Madison · N01 · FY2010 · HL
Herpesviruses as Vaccine Vectors for AIDS
$1,213,797David M Knipe · Harvard Medical School · P01 · FY2006 · AI
Age, Gene/Environment Susceptibility Study
$1,213,780Tamara Harris · National Institute On Aging · ZIA · FY2012 · AG
Effects of IL-6 blockade in treated HIV infection
$1,213,749Michael Marcel Lederman · Case Western Reserve University · U01 · FY2017 · AI
Activating Cell Death Pathways in Breast Cancer Cells
$1,213,551Stanley Lipkowitz · Division Of Clinical Sciences - Nci · ZIA · FY2025 · CA
Signaling in Airway Inflammation
$1,213,096Allan R. Brasier · University Of Texas Med Br Galveston · P01 · FY2010 · AI
Effects of Medication for Opioid Use Disorder on Microglial Activation and Neurocognition in People Living with HIV
$1,213,037Shelli Farhadian · Yale University · R01 · FY2024 · DA
Role of CEBP transcription factors in regulating cell growth and tumorigenesis
$1,212,905Peter F Johnson · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
Recipient Epidemiology and Donor Evaluation Study III (REDS-III) Central Lab
$1,212,889Michael Busch · Vitalant · N01 · FY2016 · HL
Novel humanized mouse model developed from cord blood CD34 positive HSC and autologous iPS cell derived thymus
$1,212,059Michael Allen Brehm · Univ Of Massachusetts Med Sch Worcester · R01 · FY2019 · AI
"1/9-Predictors and Mechanisms of Conversion to Psychosis
$1,211,935Tyrone D Cannon · Yale University · U01 · FY2015 · MH
Vaccine and adjuvant Clinical GMP product development and DNA Technology platform enhancements
$1,211,603Trevor Smith · Wistar Institute · U19 · FY2024 · AI
Identification of immune evasion mechanisms in the osteosarcoma microenvironment
$1,211,593Troy McEachron · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Arthropod saliva in vector-borne disease transmission: Functional analysis of novel domains in salivary secretions
$1,211,503Eric Calvo · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI
Effects of the Next Generation TNF Inhibitor (XPro1595) on Inflammation-related Deficits in Reward Circuitry and Motivation in Depression
$1,210,682Christopher J Barnum · Inmune Bio, Inc. · R44 · FY2021 · MH
LyMB Clinical Trials Team
$1,210,652Thomas Waldmann · Division Of Basic Sciences - Nci · ZID · FY2015 · CA
Validation of a human in vitro system of hepatic steatohepatitis
$1,210,475Brian Robert Wamhoff · Hemoshear Therapeutics, Llc · R44 · FY2016 · DK